The largest start-up venture capital financing in the first quarter was completed by Anthos Therapeutics Inc. with a $250m Series A round, but Series B rounds made up the largest segment of the $3.44bn raised by biopharmaceutical companies launched four years ago or less in the January-to-March period.
Biopharma start-ups raised a total of $3.44bn during the first quarter of 2019, a 26% increase from the previous quarter’s...








